Actinogen Medical (ACW) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Actinogen Medical Chart

Share price
Last
Change
Volume
Turnover
Market Cap $33.49 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)
Free until 29 Feb

The BIGGEST ASX
Spreadsheet yet!

Download in Excel or PDF for printing

Data on 1,800+ ASX Companies

  • 12-month Price Targets

  • EPS & Dividends

  • 52w Highs & Lows

It's FREE until 29 February

The BIGGEST ASX Spreadsheet yet! Current Price vs 1 Yr Target Current Price from 52w High Broker Consensus Share Price Data Fundamentals Broker Consensus

ACW Statistics

21 February

1,245 / 2,267

ASX Size Rank

1yr Return

vs Sector (1yr)

-108.79%

vs ASX 200 (1yr)

-60.73%

$33.49 million

Market Cap

Share Issue

1.12 billion

All Ords (%)

N/A

Short Sold

0.02%

Current Fundamentals

21 February

N/A

PE Ratio

EPS ($)

-0.009

Earnings Yield

-30.00%

NTA ($)

0.01

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.

Former Names
Actinogen Limited (ACW), 17/11/2015

Actinogen Medical Logo

Corporate Details

Head Office: Sydney
Managing Director: John (Bill) Ketelbey
GICS Sub-Industry: Biotechnology
Date Listed: 16 Oct 2007
Registry: Link Market Services
Similar Companies: CSL / AVH / MSB / CUV / OPT

Upcoming Calendar

14 Aug 2020 Report (Annual)
14 Aug 2020 Report (Prelim)
20 Oct 2020 Report (Annual)
18 Feb 2021 Report (Interim)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

ACW is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Dr George Morstyn Non-Executive Director Dec 2017
Mr Malcolm John McComas Non-Executive Director Apr 2019
Dr Geoffrey E.D Brooke Non-Executive Chairman, Non-Executive Director Mar 2017
Dr John (Bill) William Ketelbey Chief Executive Officer, Managing Director Dec 2014

Director Transactions

About the Data

ACW directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
31/01/20 John (Bill) Ketelbey Cancelled 3,000,000 $0.035 $105,000 Cancellation of securities.
22/11/19 John (Bill) Ketelbey Transfer 9,000,000 $0.050 $450,000 As advised by the company.
12/04/19 Malcolm McComas Issued 3,000,000 $0.052 $156,000 Issue of options.
13/12/18 George Morstyn Issued 1,500,000 $0.048 $72,000 Issue of options.
13/12/18 Geoffrey Brooke Issued 4,900,000 $0.048 $235,200 Issue of options.
13/12/18 John (Bill) Ketelbey Issued 11,700,000 $0.048 $561,600 Issue of options.
13/07/18 Geoffrey Brooke Issued 300,000 $0.050 $15,000 Participation in share purchase plan.
13/07/18 John (Bill) Ketelbey Issued 300,000 $0.050 $15,000 Participation in share purchase plan.
01/06/18 George Morstyn Buy +200,000 $0.051 $10,282 On-market trade.
22/01/18 Geoffrey Brooke Issued 625,000 $0.040 $25,000 Placement.
22/01/18 Geoffrey Brooke Issued 312,500 $0.041 $12,812 Placement.
21/12/17 Geoffrey Brooke Issued 53,333 $0.044 $2,346 Issue of options.
21/12/17 Jason Loveridge Issued 3,716,677 $0.044 $163,533 Issue of options.
21/12/17 John (Bill) Ketelbey Issued 1,647,172 $0.044 $72,475 Issue of options.
06/07/17 Anton Uvarov Transfer 187,244 $0.061 $11,473 Off-market transfer.
29/03/17 Geoffrey Brooke Buy +400,000 $0.066 $26,521 On-market trade.
24/03/17 Geoffrey Brooke Issued 5,000,000 $0.060 $300,000 Issue of securities.
24/12/15 John (Bill) Ketelbey Buy +10,909 $0.058 $629
20/05/15 John (Bill) Ketelbey Issued 157,894 $0.095 $15,000
20/05/15 Jason Loveridge Issued 157,894 $0.095 $15,000
20/05/15 Anton Uvarov Issued 157,894 $0.095 $15,000
20/05/15 Martin Rogers Issued 157,894 $0.095 $15,000
01/12/14 Anton Uvarov Buy +2,000,000 $0.020 $40,000
01/12/14 Brendan de Kauwe Buy +2,500,000 $0.020 $50,000
12/12/13 Daniel Parasiliti Issued 1,000,000 $0.010 $10,000
12/12/13 Brendan De Kauwe Issued 2,000,000 $0.010 $20,000
09/07/13 Zhukov (Zeke) Pervan Buy +66,666 $0.021 $1,381
02/07/13 Zhukov (Zeke) Pervan Transfer 9,333 $1.000 $9,333
02/07/13 Zhukov (Zeke) Pervan Transfer 933,334 $0.010 $9,333
19/06/13 Zhukov (Zeke) Pervan Transfer 5,666,666 $0.019 $107,666
19/06/13 David Zohar Buy +221,830 $0.019 $4,214
08/04/13 David Zohar Buy +142,017 $0.023 $3,266
02/04/13 David Zohar Buy +20,000 $0.022 $440
02/04/13 David Zohar Expiry 11,750,000 $0.021 $246,750

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 48 88 268 1,473 932 2,809

Top 20 Shareholders

About the Data

Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 226,324,149 20.22%
Edinburgh Technology Fund Limited 48,147,864 4.30%
Tisia Nominees Pty Ltd 29,867,184 2.67%
Mrs Sarah Cameron 25,174,137 2.25%
Mr Ross Edward Gustafson 22,877,572 2.04%
Jinark Pty Ltd 20,360,843 1.82%
Bannaby Investments Pty Limited 17,976,761 1.61%
Sunset Capital Management Pty Ltd 15,392,421 1.38%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd DRP 14,302,319 1.28%
Comsec Nominees Pty Limited 12,891,130 1.15%
Dr John William Ketelbey 12,157,894 1.09%
Brazil Farming Pty Ltd 11,000,000 0.98%
Mr Steven Veronese 10,008,001 0.89%
Oaktone Nominees Pty Ltd 10,000,000 0.89%
Tets Pty Ltd 10,000,000 0.89%
Citicorp Nominees Pty Limited 8,869,221 0.79%
Griffin & Grace Investments Pty Ltd 8,500,000 0.76%
Romfal Sifat Pty Ltd 8,000,000 0.71%
Mr Alan Giles Sauran 7,600,000 0.68%
BNP Parabis Nominees Pty Ltd 7,560,729 0.68%
All other shareholders 52.92 %


The Top 20 Shareholders of ACW hold 47.08% of shares on issue.

ACW Share Price History

Date Close Change % Change Open High Low Volume Turnover

ACW Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2018 $0.048 29 June
2017 $0.061 28 June
2016 $0.072 28 June
2015 $0.072 30 June
2014 $0.011 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases.

Incorporated: Actinogen Limited was incorporated on 26/03/1999 in Western Australia.

Suite 901, Level 9, 109 Pitt St
Sydney NSW 2000


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.